In this month’s podcast, Medtech Insight's Reed Miller, Marion Webb, and Barnaby Pickering provide a recap of our digital health coverage from December and January, including Exec Chats with the CEOs of iRhythm and Cognetivity, discuss the potential of digital therapeutics for better health, including a company profile on Akili Interactive, and highlight innovative companies working on brain and neuro functions.

Listen to the podcast via the player below:

Medtech Insight articles addressing topics discussed in this episode:

‘Training People To Be Healthier’: Digital Therapeutics Programmed For Growth

Kids, Time To Play Your Medicine: Akili Prepares Launch Of EndeavorRx Video Game For ADHD

CES 2022: Abbott CEO Robert Ford Announces New Biowearables Line For Consumers, Paving the Way From Measuring Glucose To Ketone, Lactate, Alcohol

Minute Insight: Agendia Collaborates With Illumina And Brazilian Health Care Providers

Money And Materials Will Allow Medtech To Restore Lost Neuro Functions

Stryker Invests Big In Connected Health Care With $3.09Bn Acquisition Of Vocera

Renalytix Collaborates With ADA To Improve Early Detection Of Kidney Disease

Exec Chat: Cognetivity’s Simple Brain Test Could Unlock Trillions In Health Care Savings

Exec Chat: New iRhythm CEO Foresees Enormous Opportunity In AI For Arrhythmia Detection

Scrip’s Five Must-Know Things – 24 January 2022 by Citeline

On this week’s podcast, Medtech Insight's Reed Miller, Marion Webb and Barnaby Pickering provide a recap of our J.P. Morgan Health Care conference coverage including Abbott, Dexcom, Zimmer Biomet and Nuvasive and spotlight Scottish company PneumoWave.

Listen to the podcast via the player below:

Medtech Insight articles addressing topics discussed in this episode:

https://medtech.pharmaintelligence.informa.com/MT144959/Start-up-Spotlight-PneumoWave-Hopes-Sensor-Tech-Can-Prevent-Opioid-Deaths

https://medtech.pharmaintelligence.informa.com/MT144948/JPM-2022-Abiomed-Penumbra-Renalityx

https://medtech.pharmaintelligence.informa.com/MT144941/JPM-2022-Boston-Scientific-Inspire-Nuvasive-Vericel

https://medtech.pharmaintelligence.informa.com/MT144939/JPM-2022-MidWeek-IVD-Roundup-Guardant-Illumina-Ortho-Clinical-Thermo-Fisher

https://medtech.pharmaintelligence.informa.com/MT144935/JPM-2022-Abbott-iRhythm-Novocure-Zimmer-Biomet

For more information on Medtech Insight and to start a free trial, click here:

http://bit.ly/2w7LnlR

Pink Sheet reporters and editors discuss how the hearings for the withdrawal of Avastin’s accelerated approval in breast cancer could inform the same process for Makena, Robert Califf’s view that public trust in the agency will be rebuilt, and a request to increase the dispensing fees associated with COVID-19 treatments Paxlovid and molnupiravir.

For more details see https://pharmaintelligence.informa.com/events/awards/japan-awards-2022 (English) or https://pharmaintelligence.informa.com/ja-jp/events/awards/japan-awards-2022 (Japanese)

In this episode of Speaking Of Medtech we’re breaking out the crystal ball to give a few predictions of what could be in store this year for industry and the FDA’s Center for Devices and Radiological Health. From the ongoing COVID-19 pandemic to digital devices and facility inspections, there’s a lot of ground to cover.

Medtech Insight article addressing topics discussed in this episode:

• Happy New Year! (I Think?): Some 2022 Predictions For FDA’s Device Center - https://medtech.pharmaintelligence.informa.com/MT144897/Happy-New-Year-I-Think-Some-2022-Predictions-For-FDAs-Device-Center

In this first edition of “Report Digest,” UK-based reporter Barnaby Pickering discusses the liquid biopsy for oncology market with analyst, Phil Greenfield. The two discuss the main market drivers, and exactly what experts think will occur in the sector in future years.

For more information, take a look at Meddevicetracker’s report, here - https://www.meddevicetracker.com/ReportDetail.cfm?ReportID=477

Scrip’s Five Must-Know Things – 17 January 2022 by Citeline

On this week’s podcast: From Hawaii to Missouri to Florida, the medtech industry and third-party servicers are duking it out in state legislatures over who has the right to repair and service medical devices.

Medtech Insight articles addressing topics discussed in this episode:

• Right To Repair Proponents Gearing Up To Fight In State Legislatures Again

Pink Sheet reporter and editors discuss the CMS coverage decision for Biogen and Eisai’s Alzheimer’s treatment Aduhelm, the FDA conducting fewer advisory committee meetings in 2021 and the Defense Department’s efforts to increase domestic drug production.